Laminin gamma 1 Antibody (D18) [DyLight 755]
Novus Biologicals, part of Bio-Techne | Catalog # FAB2139Z
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human, Rat
Applications
Western Blot, Immunocytochemistry, Immunoprecipitation
Label
DyLight 755 (Excitation = 754 nm, Emission = 776 nm)
Antibody Source
Monoclonal Mouse IgG2A Clone # D18
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Rat glomerular basement membrane
Specificity
Detects human and rat Laminin gamma1.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2A
Applications for Laminin gamma 1 Antibody (D18) [DyLight 755]
Application
Recommended Usage
Immunocytochemistry
Optimal dilutions of this antibody should be experimentally determined.
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Laminin gamma 1
Alternate Names
LAMC1, Laminin B2
Gene Symbol
LAMC1
Additional Laminin gamma 1 Products
Product Documents for Laminin gamma 1 Antibody (D18) [DyLight 755]
Product Specific Notices for Laminin gamma 1 Antibody (D18) [DyLight 755]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...